Fundraising FoxNextGen Venture Partners — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
Replacing passwords with biometric authentication
Frances Zelazny(Founder)in
Co-investorsAperture Venture CapitalFINTOP CapitalReflexive CapitalSwitch VenturesTarget GlobalTFX Capital+4 more
Clear Street provides an institutional-grade trading platform that combines AI-powered market insights, multi-asset class access, and low-latency execution infrastructure for active traders across equities, options, and international markets.
AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareFintechNew York, US
Chris Pento(Founder)inUri Cohen(Founder & CEO)inJonathan Daplyn(Executive Officer)inJohn Levene(Executive Officer)inEdward T. Tilly(Executive Officer)Steven Bisgay(Executive Officer)
Co-investorsBelvedere Strategic CapitalPrysm CapitalSeason Two VenturesBaillie GiffordIllia PolosukhinNear Foundation
ShennonBio develops immunotherapy technologies using microfluidic engineering, computational biology, and immunology to advance T cell engineering for cancer treatment.
AI & Machine LearningBiotechDeep TechMedical DevicesSan Francisco, US
Li Sun, PhD(Founder/CEO)in
BoardJAMES HARDIMAN(Director)in
Co-investorsAV8 VenturesDCVC (Data Collective)Foundation CapitalFuture VenturesSamos Investments
Vistapath develops technology solutions to modernize pathology lab operations, helping pathology laboratories improve quality, efficiency, and consistency in critical lab processes.
AI & Machine LearningHealthtechMedical DevicesCambridge, US
Timothy Spong(CEO & Founder)inBen Burley(COO & Founder)inBurley Benjamin(Executive Officer, Director)Jacob Guggenheim(CTO)in
Co-investorsCota CapitalFirst Star VenturesMoxxie VenturesOlima VenturesScribble VenturesSpero Ventures+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.